PPP2R2D suppresses IL-2 production and Treg function

Area of Science:

• Immunology
• Molecular Biology
• Autoimmunity

Background:

• Protein phosphatase 2A (PP2A) is crucial in cellular processes and implicated in autoimmunity.
• Decreased interleukin-2 (IL-2) production is a hallmark of systemic autoimmunity.
• Specific regulatory subunits of PP2A may control IL-2 production and autoimmune responses.

Purpose of the Study:

• To investigate the role of specific PP2A regulatory subunits in T cell function and autoimmunity.
• To determine if PPP2R2D influences IL-2 production in systemic lupus erythematosus (SLE).
• To explore the therapeutic potential of targeting PP2A regulatory subunits.

Main Methods:

• Analysis of PPP2R2D levels in T cells from SLE patients.
• Generation of mice with T cell-specific deletion of PPP2R2D.
• Assessment of IL-2 production, gene expression, and CREB phosphorylation in T cells.
• Evaluation of autoimmune phenotypes in mice upon TLR7 stimulation.
• In vitro and in vivo functional assays for regulatory T cell (Treg) suppressive capacity.

Main Results:

• PPP2R2D is upregulated in T cells from individuals with SLE and regulates IL-2 production.
• T cell-specific deletion of PPP2R2D leads to increased IL-2 production due to open gene loci and high CREB phosphorylation.
• Mice lacking T cell PPP2R2D exhibit reduced systemic autoimmunity following TLR7 stimulation.
• Tregs maintain high suppressive function in vitro and in vivo, irrespective of PPP2R2D levels.

Conclusions:

• PPP2R2D is a key regulator of IL-2 production and T cell-mediated autoimmunity.
• Targeting specific PP2A regulatory subunits like PPP2R2D offers a potential strategy for developing function-specific immunotherapies.
• This finding opens avenues for novel treatments for autoimmune diseases by modulating specific T cell functions.